Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Nov 2025 for NEPHROS INC.
Insider track record
Disclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Oliver J. Spandow: trading record in brief
Oliver J. Spandow is a declared insider of Nephros Inc (board member), with filings sourced from SEC (Form 4). In total, 10 filings cover trades dated from 14 December 2018 to 10 November 2025.
Every open-market trade on record is a purchase: 2 purchases worth €15k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 8 share grants.
On 13 November 2025 came the latest disclosure, a share grant in Nephros Inc. The last insider purchase was made public on 20 November 2020, 2,163 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Oliver J. Spandow
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
8,036 shares0Common StockSEC:0000914190-25-000040:0
33,241 shares0Common StockSEC:0001062993-25-000233:0
14,294 shares0Common StockSEC:0001062993-23-022645:0
42,481 shares0Common StockSEC:0001062993-23-000720:0
5,429 shares0Common StockSEC:0001437749-21-028834:0
5 of 5 declarations
